Digital Pathology Market Size, Share & Trends by Product (Scanner, Software, Storage System), Type (Human, Veterinary), Application (Teleconsultation, Training, Disease Diagnosis, Drug Discovery), End User (Pharma & Biotech, Academia, Hospitals) - Global

Digital Pathology Market Size, Share & Trends by Product (Scanner, Software, Storage System), Type (Human, Veterinary), Application (Teleconsultation, Training, Disease Diagnosis, Drug Discovery), End User (Pharma & Biotech, Academia, Hospitals) - Global Forecast to 2029

The global digital pathology market is projected to reach USD 2.0 billion by 2029 from USD 1.1 billion in 2024, at a CAGR of 13.1% from 2024 to 2029. The growth of the market is fuelled due to advancements in technology, such as high-resolution scanners, sophisticated imaging software, and AI-powered analytics, significantly improve the accuracy and efficiency of pathology workflows. The increasing prevalence of chronic diseases, including cancer, necessitates rapid and precise diagnostic tools, which digital pathology readily provides. Moreover, the push towards personalized medicine and targeted therapies requires detailed tissue analysis that digital pathology can deliver.

“Scanners segment held the largest share in the global Digital Pathology market during the forecast period.”

On the basis type, the Digital Pathology market is segmented into scanners, software, and storage systems segment. The scanners segment accounted for the largest share of the product segment in 2023 because these devices are essential to the digital pathology process. Scanners transform glass slides into high-resolution digital images, allowing pathologists to view and analyze specimens on computer screens. The critical role of scanners in enabling remote diagnostics drives their demand, as they allow pathologists to review cases from any location, thereby improving accessibility and efficiency in pathology services. Furthermore, advancements in scanner technology, such as higher resolution imaging and faster scanning speeds, enhance diagnostic accuracy and workflow efficiency, making them a valuable investment for laboratories and healthcare facilities.

“By type, human pathology holds the largest share during the forecast period.”

Based on type, the Digital Pathology market is segmented into human pathology and veterinary pathology. Human pathology holds the largest share during forecast period. Firstly, the rising prevalence of chronic diseases such as cancer demands advanced diagnostic tools for accurate and timely detection. Digital pathology offers significant advantages over traditional methods, including enhanced image analysis, superior storage and retrieval capabilities, and the ease of sharing digital slides for remote consultations and second opinions. Moreover, technological advancements like artificial intelligence and machine learning are increasingly being integrated into digital pathology, equipping pathologists with powerful tools for improved diagnostic accuracy and efficiency.

“The Drug Discovery segment accounted for the largest share of the global Digital Pathology market during the forecast period.”

Based on application, the Digital Pathology market is segmented into drug discovery, disease diagnosis, training and education segment. The drug discovery segment accounted for the largest share of the application segment in 2023. This is due to the accuracy of the drug development process. Consequently, integrating digital pathology into drug discovery workflows significantly boosts productivity, drives innovation, and shortens the time-to-market for new drugs, cementing its dominant position in this market segment.

“Pharmaceutical and biotechnology companies are largest end users of the Digital Pathology market.”

Based on end users, the Digital Pathology market is segmented into pharmaceutical and biotechnology companies, hospital and reference laboratories, and academic and research institutes. The pharmaceutical and biotechnology companies held the largest share in 2023. The scalability of digital pathology solutions aligns well with the large volumes of samples that pharmaceutical and biotechnology companies handle, providing them with a critical tool to accelerate research and development, ultimately leading to faster time-to-market for new therapies. This combination of improved efficiency, accuracy, and collaboration makes digital pathology an invaluable asset for these companies, thus driving their dominant market share.

“North America dominates the global Digital Pathology market.”

The Digital Pathology market is segmented into five major regional segments, namely, North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. In 2023, North America accounted for the largest share of the Digital Pathology market. This is due to its advanced healthcare infrastructure and significant investment in healthcare technologies, allowing for the adoption of cutting-edge digital pathology systems. Also, regulatory frameworks in countries like the US and Canada are supportive of the adoption of advanced medical technologies, ensuring a streamlined approval process for digital pathology solutions.

Breakdown of supply-side primary interviews, by company type, designation, and region:

By Company Type: Tier 1 (35%), Tier 2 (45%), and Tier 3 (20%)

By Designation: C-level (35%), Director-level (25%), and Others (40%)

By Region: North America (40%), Europe (30%), Asia Pacific (20%), Latin America (5%) and Middle East Africa (5%)

List of Companies Profiled in the Report

Danaher Corporation (US)

Koninklijke Philips N.V. (Netherlands)

Hamamatsu Photonics K.K. (Japan)

F. Hoffmann-La Roche Ltd. (Switzerland)

3DHISTECH (Hungary)

Apollo Enterprise Imaging (US)

XIFIN, Inc. (US)

Huron Digital Pathology (Canada)

Hologic, Inc. (US)

Corista (US)

Indica Labs Inc. (US)

Objective Pathology Services Limited (Canada)

Sectra AB (Sweden)

OptraSCAN (US)

Akoya Biosciences, Inc. (US)

Glencoe Software, Inc. (US)

Aiforia (Finland)

Paige AI, Inc. (US)

Fujifilm Holdings Corporation (Japan)

Proscia Inc. (US)

KONFOONG BIOTECH INTERNATIONAL CO., LTD. (China)

Mikroscan Technologies, Inc. (US)

PathAI (US)

Motic Digital Pathology (US)

Kanteron Systems (Spain)

Research Coverage

This report studies the digital pathology market based on product, type, application, end user, and region. The report also analyses factors (such as drivers, opportunities and challenges) affecting market growth. It evaluates the opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders. The report also studies micro markets with respect to their growth trends, prospects, and contributions to the total digital pathology market. The report forecasts the revenue of the market segments with respect to five major regions.

Reasons to Buy the Report

This report also includes.

Analysis of key drivers (advancements in image analysis algorithms, artificial intelligence (AI) applications for pattern recognition, and cloud-based solutions that enhance scalability and accessibility), restrains (lack of trained pathologits and high capital investment), challenges (data privacy concerns), opportunities (expansion in emerging market and personalized medicine and biomarker discovery) are contributing the growth of the digital pathology market.

Product Development/Innovation: Detailed insights on upcoming trends, research & development activities, and new software launches in the digital pathology market.

Market Development: Comprehensive information on the lucrative emerging markets, products, type, application, end-user, and region.

Market Diversification: Exhaustive information about the software portfolios, growing geographies, recent developments, investments in the digital pathology market.

Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, company evaluation quadrant, and capabilities of leading players in the global digital pathology Market.

List of Tables

Table 1 Factor Analysis

Table 2 Risk Assessment

Table 3 Incidence Of Cancer, By Region, 2020 Vs. 2030 Vs. 2040 (Million)

Table 4 Us: Growth In Number Of Personalized Medicines (2008−2020)

Table 5 Number Of Inhabitants Per Pathologist, By Country, 2020

Table 6 Average Selling Price Trend Of Digital Pathology Products, By Region

Table 7 Average Selling Price Of Digital Pathology Products

Table 8 Digital Pathology Market: Porter’s Five Forces

Table 9 Regulatory Bodies, Government Agencies, And Other Organizations

Table 10 Us Fda: Medical Device Classification

Table 11 Us: Medical Device Regulatory Approval Process

Table 12 Canada: Medical Device Regulatory Approval Process

Table 13 Europe: Classification Of Ivd Devices

Table 14 Japan: Medical Device Classification Under Pmda

Table 15 China: Classification Of Medical Devices

Table 16 Hs Code: Digital Pathology Scanner

Table 17 Case Study 1: Assessing Image Quality For Comparative Multi-assessment Evaluation Of Aperio Gt 450 Dx

Table 18 Case Study 2: Promotion Of Pathology Workflow Efficiency

Table 19 Case Study 3: Integration Of Artificial Intelligence In Digital Pathology

Table 20 Digital Pathology Market: Key Conferences & Events, 2024−2025

Table 21 Stakeholders In Buying Process: Definitions

Table 22 Influence Of Stakeholders On Buying Process For Digital Pathology, By Product

Table 23 Key Buying Criteria For Digital Pathology Products

Table 24 Unmet Needs In Digital Pathology Market

Table 25 End-user Expectations In Digital Pathology Market

Table 26 Digital Pathology Market, By Product, 2022–2029 (Usd Million)

Table 27 Scanning Magnification And Applications

Table 28 Digital Pathology Scanners Offered By Key Market Players

Table 29 Digital Pathology Market For Scanners,

By Type, 2022–2029 (Usd Million)

Table 30 Digital Pathology Market For Scanners,

By Country, 2022–2029 (Usd Million)

Table 31 Brightfield Scanners Offered By Key Market Players

Table 32 Brightfield Scanners Market, By Country, 2022–2029 (Usd Million)

Table 33 Fluorescence Scanners Offered By Key Market Players

Table 34 Fluorescence Scanners Market, By Country, 2022–2029 (Usd Million)

Table 35 Other Scanners Offered By Key Market Players

Table 36 Other Scanners Market, By Country, 2022–2029 (Usd Million)

Table 37 Digital Pathology Software Offered By Key Market Players

Table 38 Digital Pathology Market For Software,

By Type, 2022–2029 (Usd Million)

Table 39 Digital Pathology Market For Software,

By Country, 2022–2029 (Usd Million)

Table 40 Integrated Software Offered By Key Market Players

Table 41 Integrated Software Market, By Country, 2022–2029 (Usd Million)

Table 42 Standalone Software Market, By Type, 2022–2029 (Usd Million)

Table 43 Standalone Software Market, By Country, 2022–2029 (Usd Million)

Table 44 Information Management Software Offered By Key Market Players

Table 45 Information Management Software Market,

By Country, 2022–2029 (Usd Million)

Table 46 Image Analysis Software Offered By Key Market Players

Table 47 Image Analysis Software Market, By Country, 2022–2029 (Usd Million)

Table 48 Digital Pathology Market For Software,

By Deployment Model, 2022–2029 (Usd Million)

Table 49 Cloud-based Software Offered By Key Market Players

Table 50 Cloud-based Model Market, By Country, 2022–2029 (Usd Million)

Table 51 On-premise Software Offered By Key Market Players

Table 52 On-premise Model Market, By Country, 2022–2029 (Usd Million)

Table 53 Hybrid Software Offered By Key Market Players

Table 54 Hybrid Model Market, By Country, 2022–2029 (Usd Million)

Table 55 Storage Systems Offered By Key Market Players

Table 56 Digital Pathology Market For Storage Systems,

By Country, 2022–2029 (Usd Million)

Table 57 Digital Pathology Market, By Type, 2022–2029 (Usd Million)

Table 58 Human Digital Pathology Market, By Country, 2022–2029 (Usd Million)

Table 59 Veterinary Digital Pathology Market,

By Country, 2022–2029 (Usd Million)

Table 60 Digital Pathology Market, By Application, 2022–2029 (Usd Million)

Table 61 Software Impact Analysis, By Application

Table 62 Digital Pathology Applications In Drug Discovery

Table 63 Digital Pathology Market For Drug Discovery,

By Country, 2022–2029 (Usd Million)

Table 64 Digital Pathology Market For Disease Diagnosis,

By Country, 2022–2029 (Usd Million)

Table 65 Digital Pathology Market For Training & Education,

By Country, 2022–2029 (Usd Million)

Table 66 Digital Pathology Market, By End User, 2022–2029 (Usd Million)

Table 67 Software Impact Analysis, By End User

Table 68 Digital Pathology Market For Pharmaceutical & Biotechnology Companies, By Country, 2022–2029 (Usd Million)

Table 69 Deployment Of Digital Pathology Solutions In Hospitals

Table 70 Digital Pathology Market For Hospitals And Reference Laboratories, By Country, 2022–2029 (Usd Million)

Table 71 Digital Pathology Market For Academic & Research Institutes,

By Country, 2022–2029 (Usd Million)

Table 72 Digital Pathology Market, By Region, 2022–2029 (Usd Million)

Table 73 North America: Digital Pathology Market, By Country,

2022–2029 (Usd Million)

Table 74 North America: Digital Pathology Market, By Product,

2022–2029 (Usd Million)

Table 75 North America: Digital Pathology Market For Scanners,

By Type, 2022–2029 (Usd Million)

Table 76 North America: Digital Pathology Market For Software,

By Type, 2022–2029 (Usd Million)

Table 77 North America: Standalone Software Market,

By Type, 2022–2029 (Usd Million)

Table 78 North America: Digital Pathology Market For Software,

By Deployment Model, 2022–2029 (Usd Million)

Table 79 North America: Digital Pathology Market,

By Type, 2022–2029 (Usd Million)

Table 80 North America: Digital Pathology Market,

By Application, 2022–2029 (Usd Million)

Table 81 North America: Digital Pathology Market,

By End User, 2022–2029 (Usd Million)

Table 82 Us: Cancer Incidence, By Cancer Type, 2020 Vs. 2040

Table 83 Us: Key Macroindicators

Table 84 Us: Digital Pathology Market, By Product, 2022–2029 (Usd Million)

Table 85 Us: Digital Pathology Market For Scanners,

By Type, 2022–2029 (Usd Million)

Table 86 Us: Digital Pathology Market For Software,

By Type, 2022–2029 (Usd Million)

Table 87 Us: Standalone Software Market, By Type, 2022–2029 (Usd Million)

Table 88 Us: Digital Pathology Market For Software,

By Deployment Model, 2022–2029 (Usd Million)

Table 89 Us: Digital Pathology Market, By Type, 2022–2029 (Usd Million)

Table 90 Us: Digital Pathology Market, By Application, 2022–2029 (Usd Million)

Table 91 Us: Digital Pathology Market, By End User, 2022–2029 (Usd Million)

Table 92 Canada: Cancer Incidence, By Cancer Type, 2020 Vs. 2040

Table 93 Canada: Funding Initiatives For Digital Pathology

Table 94 Canada: Key Macroindicators

Table 95 Canada: Digital Pathology Market, By Product, 2022–2029 (Usd Million)

Table 96 Canada: Digital Pathology Market For Scanners,

By Type, 2022–2029 (Usd Million)

Table 97 Canada: Digital Pathology Market For Software,

By Type, 2022–2029 (Usd Million)

Table 98 Canada: Standalone Software Market, By Type, 2022–2029 (Usd Million)

Table 99 Canada: Digital Pathology Market For Software,

By Deployment Mode, 2022–2029 (Usd Million)

Table 100 Canada: Digital Pathology Market, By Type, 2022–2029 (Usd Million)

Table 101 Canada: Digital Pathology Market, By Application,

2022–2029 (Usd Million)

Table 102 Canada: Digital Pathology Market, By End User,

2022–2029 (Usd Million)

Table 103 Europe: Digital Pathology Market, By Country, 2022–2029 (Usd Million)

Table 104 Europe: Digital Pathology Market, By Product, 2022–2029 (Usd Million)

Table 105 Europe: Digital Pathology Market For Scanners,

By Type, 2022–2029 (Usd Million)

Table 106 Europe: Digital Pathology Market For Software,

By Type, 2022–2029 (Usd Million)

Table 107 Europe: Standalone Software Market, By Type, 2022–2029 (Usd Million)

Table 108 Europe: Digital Pathology Market For Software,

By Deployment Model, 2022–2029 (Usd Million)

Table 109 Europe: Digital Pathology Market, By Type, 2022–2029 (Usd Million)

Table 110 Europe: Digital Pathology Market, By Application,

2022–2029 (Usd Million)

Table 111 Europe: Digital Pathology Market, By End User,

2022–2029 (Usd Million)

Table 112 Germany: Cancer Incidence, By Cancer Type, 2020 Vs. 2040

Table 113 Germany: Key Macroindicators

Table 114 Germany: Digital Pathology Market, By Product,

2022–2029 (Usd Million)

Table 115 Germany: Digital Pathology Market For Scanners,

By Type, 2022–2029 (Usd Million)

Table 116 Germany: Digital Pathology Market For Software,

By Type, 2022–2029 (Usd Million)

Table 117 Germany: Standalone Software Market,

By Type, 2022–2029 (Usd Million)

Table 118 Germany: Digital Pathology Market For Software,

By Deployment Mode, 2022–2029 (Usd Million)

Table 119 Germany: Digital Pathology Market, By Type, 2022–2029 (Usd Million)

Table 120 Germany: Digital Pathology Market, By Application,

2022–2029 (Usd Million)

Table 121 Germany: Digital Pathology Market, By End User,

2022–2029 (Usd Million)

Table 122 Uk: Cancer Incidence, By Type, 2020 Vs. 2040

Table 123 Uk: Key Macroindicators

Table 124 Uk: Digital Pathology Market, By Product, 2022–2029 (Usd Million)

Table 125 Uk: Digital Pathology Market For Scanners,

By Type, 2022–2029 (Usd Million)

Table 126 Uk: Digital Pathology Market For Software,

By Type, 2022–2029 (Usd Million)

Table 127 Uk: Standalone Software Market, By Type, 2022–2029 (Usd Million)

Table 128 Uk: Digital Pathology Market For Software,

By Deployment Mode, 2022–2029 (Usd Million)

Table 129 Uk: Digital Pathology Market, By Type, 2022–2029 (Usd Million)

Table 130 Uk: Digital Pathology Market, By Application, 2022–2029 (Usd Million)

Table 131 Uk: Digital Pathology Market, By End User, 2022–2029 (Usd Million)

Table 132 Sweden: Cancer Incidence, By Cancer Type, 2020 Vs. 2040

Table 133 Sweden: Key Macroindicators

Table 134 Sweden: Digital Pathology Market, By Product,

2022–2029 (Usd Million)

Table 135 Sweden: Digital Pathology Market For Scanners,

By Type, 2022–2029 (Usd Million)

Table 136 Sweden: Digital Pathology Market For Software,

By Type, 2022–2029 (Usd Million)

Table 137 Sweden: Standalone Software Market,

By Type, 2022–2029 (Usd Million)

Table 138 Sweden: Digital Pathology Market For Software,

By Deployment Mode, 2022–2029 (Usd Million)

Table 139 Sweden: Digital Pathology Market, By Type, 2022–2029 (Usd Million)

Table 140 Sweden: Digital Pathology Market, By Application,

2022–2029 (Usd Million)

Table 141 Sweden: Digital Pathology Market, By End User,

2022–2029 (Usd Million)

Table 142 Denmark: Cancer Incidence, By Cancer Type, 2020 Vs. 2040

Table 143 Denmark: Digital Pathology Market, By Product,

2022–2029 (Usd Million)

Table 144 Denmark: Digital Pathology Market For Scanners,

By Type, 2022–2029 (Usd Million)

Table 145 Denmark: Digital Pathology Market For Software,

By Type, 2022–2029 (Usd Million)

Table 146 Denmark: Standalone Software Market, By Type,

2022–2029 (Usd Million)

Table 147 Denmark: Digital Pathology Market For Software,

By Deployment Mode, 2022–2029 (Usd Million)

Table 148 Denmark: Digital Pathology Market, By Type, 2022–2029 (Usd Million)

Table 149 Denmark: Digital Pathology Market, By Application,

2022–2029 (Usd Million)

Table 150 Denmark: Digital Pathology Market, By End User,

2022–2029 (Usd Million)

Table 151 France: Cancer Incidence, By Cancer Type, 2020 Vs. 2040

Table 152 France: Digital Pathology Market, By Product, 2022–2029 (Usd Million)

Table 153 France: Digital Pathology Market For Scanners,

By Type, 2022–2029 (Usd Million)

Table 154 France: Digital Pathology Market For Software,

By Type, 2022–2029 (Usd Million)

Table 155 France: Standalone Software Market, By Type, 2022–2029 (Usd Million)

Table 156 France: Digital Pathology Market For Software,

By Deployment Mode, 2022–2029 (Usd Million)

Table 157 France: Digital Pathology Market, By Type, 2022–2029 (Usd Million)

Table 158 France: Digital Pathology Market, By Application,

2022–2029 (Usd Million)

Table 159 France: Digital Pathology Market, By End User,

2022–2029 (Usd Million)

Table 160 Spain: Digital Pathology Market, By Product, 2022–2029 (Usd Million)

Table 161 Spain: Digital Pathology Market For Scanners,

By Type, 2022–2029 (Usd Million)

Table 162 Spain: Digital Pathology Market For Software,

By Type, 2022–2029 (Usd Million)

Table 163 Spain: Standalone Software Market, By Type, 2022–2029 (Usd Million)

Table 164 Spain: Digital Pathology Market For Software,

By Deployment Model, 2022–2029 (Usd Million)

Table 165 Spain: Digital Pathology Market, By Type, 2022–2029 (Usd Million)

Table 166 Spain: Digital Pathology Market, By Application,

2022–2029 (Usd Million)

Table 167 Spain: Digital Pathology Market, By End User, 2022–2029 (Usd Million)

Table 168 Italy: Digital Pathology Market, By Product, 2022–2029 (Usd Million)

Table 169 Italy: Digital Pathology Market For Scanners,

By Type, 2022–2029 (Usd Million)

Table 170 Italy: Digital Pathology Market For Software,

By Type, 2022–2029 (Usd Million)

Table 171 Italy: Standalone Software Market, By Type, 2022–2029 (Usd Million)

Table 172 Italy: Digital Pathology Market For Software,

By Deployment Mode, 2022–2029 (Usd Million)

Table 173 Italy: Digital Pathology Market, By Type, 2022–2029 (Usd Million)

Table 174 Italy: Digital Pathology Market, By Application, 2022–2029 (Usd Million)

Table 175 Italy: Digital Pathology Market, By End User, 2022–2029 (Usd Million)

Table 176 Rest Of Europe: Digital Pathology Market,

By Product, 2022–2029 (Usd Million)

Table 177 Rest Of Europe: Digital Pathology Market For Scanners,

By Type, 2022–2029 (Usd Million)

Table 178 Rest Of Europe: Digital Pathology Market For Software,

By Type, 2022–2029 (Usd Million)

Table 179 Rest Of Europe: Standalone Software Market,

By Type, 2022–2029 (Usd Million)

Table 180 Rest Of Europe: Digital Pathology Market For Software,

By Deployment Model, 2022–2029 (Usd Million)

Table 181 Rest Of Europe: Digital Pathology Market,

By Type, 2022–2029 (Usd Million)

Table 182 Rest Of Europe: Digital Pathology Market,

By Application, 2022–2029 (Usd Million)

Table 183 Rest Of Europe: Digital Pathology Market,

By End User, 2022–2029 (Usd Million)

Table 184 Asia Pacific: Digital Pathology Market,

By Country, 2022–2029 (Usd Million)

Table 185 Asia Pacific: Digital Pathology Market,

By Product, 2022–2029 (Usd Million)

Table 186 Asia Pacific: Digital Pathology Market For Scanners,

By Type, 2022–2029 (Usd Million)

Table 187 Asia Pacific: Digital Pathology Market For Software,

By Type, 2022–2029 (Usd Million)

Table 188 Asia Pacific: Standalone Software Market,

By Type, 2022–2029 (Usd Million)

Table 189 Asia Pacific: Digital Pathology Market For Software,

By Deployment Model, 2022–2029 (Usd Million)

Table 190 Asia Pacific: Digital Pathology Market, By Type, 2022–2029 (Usd Million)

Table 191 Asia Pacific: Digital Pathology Market, By Application,

2022–2029 (Usd Million)

Table 192 Asia Pacific: Digital Pathology Market, By End User,

2022–2029 (Usd Million)

Table 193 China: Cancer Incidence, By Cancer Type, 2020 Vs. 2040

Table 194 China: Digital Pathology Market, By Product, 2022–2029 (Usd Million)

Table 195 China: Digital Pathology Market For Scanners,

By Type, 2022–2029 (Usd Million)

Table 196 China: Digital Pathology Market For Software,

By Type, 2022–2029 (Usd Million)

Table 197 China: Standalone Software Market, By Type, 2022–2029 (Usd Million)

Table 198 China: Digital Pathology Market For Software,

By Deployment Mode, 2022–2029 (Usd Million)

Table 199 China: Digital Pathology Market, By Type, 2022–2029 (Usd Million)

Table 200 China: Digital Pathology Market, By Application,

2022–2029 (Usd Million)

Table 201 China: Digital Pathology Market, By End User, 2022–2029 (Usd Million)

Table 202 Japan: Cancer Incidence, By Cancer Type, 2020 Vs. 2040

Table 203 Japan: Digital Pathology Market, By Product, 2022–2029 (Usd Million)

Table 204 Japan: Digital Pathology Market For Scanners,

By Type, 2022–2029 (Usd Million)

Table 205 Japan: Digital Pathology Market For Software,

By Type, 2022–2029 (Usd Million)

Table 206 Japan: Standalone Software Market, By Type, 2022–2029 (Usd Million)

Table 207 Japan: Digital Pathology Market For Software,

By Deployment Model, 2022–2029 (Usd Million)

Table 208 Japan: Digital Pathology Market, By Type, 2022–2029 (Usd Million)

Table 209 Japan: Digital Pathology Market, By Application,

2022–2029 (Usd Million)

Table 210 Japan: Digital Pathology Market, By End User, 2022–2029 (Usd Million)

Table 211 India: Cancer Incidence, By Cancer Type, 2020 Vs. 2040

Table 212 India: Digital Pathology Market, By Product, 2022–2029 (Usd Million)

Table 213 India: Digital Pathology Market For Scanners,

By Type, 2022–2029 (Usd Million)

Table 214 India: Digital Pathology Market For Software,

By Type, 2022–2029 (Usd Million)

Table 215 India: Standalone Software Market, By Type, 2022–2029 (Usd Million)

Table 216 India: Digital Pathology Market For Software,

By Deployment Mode, 2022–2029 (Usd Million)

Table 217 India: Digital Pathology Market, By Type, 2022–2029 (Usd Million)

Table 218 India: Digital Pathology Market, By Application,

2022–2029 (Usd Million)

Table 219 India: Digital Pathology Market, By End User, 2022–2029 (Usd Million)

Table 220 Rest Of Asia Pacific: Digital Pathology Market,

By Product, 2022–2029 (Usd Million)

Table 221 Rest Of Asia Pacific: Digital Pathology Market For Scanners,

By Type, 2022–2029 (Usd Million)

Table 222 Rest Of Asia Pacific: Digital Pathology Market For Software,

By Type, 2022–2029 (Usd Million)

Table 223 Rest Of Asia Pacific: Standalone Software Market,

By Type, 2022–2029 (Usd Million)

Table 224 Rest Of Asia Pacific: Digital Pathology Market For Software,

By Deployment Mode, 2022–2029 (Usd Million)

Table 225 Rest Of Asia Pacific: Digital Pathology Market,

By Type, 2022–2029 (Usd Million)

Table 226 Rest Of Asia Pacific: Digital Pathology Market,

By Application, 2022–2029 (Usd Million)

Table 227 Rest Of Asia Pacific: Digital Pathology Market,

By End User, 2022–2029 (Usd Million)

Table 228 Latin America: Digital Pathology Market,

By Country, 2022–2029 (Usd Million)

Table 229 Latin America: Digital Pathology Market,

By Product, 2022–2029 (Usd Million)

Table 230 Latin America: Digital Pathology Market For Scanners,

By Type, 2022–2029 (Usd Million)

Table 231 Latin America: Digital Pathology Market For Software,

By Type, 2022–2029 (Usd Million)

Table 232 Latin America: Standalone Software Market,

By Type, 2022–2029 (Usd Million)

Table 233 Latin America: Digital Pathology Market For Software,

By Deployment Model, 2022–2029 (Usd Million)

Table 234 Latin America: Digital Pathology Market,

By Type, 2022–2029 (Usd Million)

Table 235 Latin America: Digital Pathology Market,

By Application, 2022–2029 (Usd Million)

Table 236 Latin America: Digital Pathology Market,

By End User, 2022–2029 (Usd Million)

Table 237 Brazil: Cancer Incidence, By Cancer Type, 2020 Vs. 2040

Table 238 Brazil: Digital Pathology Market, By Product, 2022–2029 (Usd Million)

Table 239 Brazil: Digital Pathology Market For Scanners,

By Type, 2022–2029 (Usd Million)

Table 240 Brazil: Digital Pathology Market For Software,

By Type, 2022–2029 (Usd Million)

Table 241 Brazil: Standalone Software Market, By Type, 2022–2029 (Usd Million)

Table 242 Brazil: Digital Pathology Market For Software,

By Deployment Mode, 2022–2029 (Usd Million)

Table 243 Brazil: Digital Pathology Market, By Type, 2022–2029 (Usd Million)

Table 244 Brazil: Digital Pathology Market, By Application,

2022–2029 (Usd Million)

Table 245 Brazil: Digital Pathology Market, By End User, 2022–2029 (Usd Million)

Table 246 Mexico: Cancer Incidence, By Cancer Type, 2020 Vs. 2040

Table 247 Mexico: Digital Pathology Market, By Product, 2022–2029 (Usd Million)

Table 248 Mexico: Digital Pathology Market For Scanners,

By Type, 2022–2029 (Usd Million)

Table 249 Mexico: Digital Pathology Market For Software,

By Type, 2022–2029 (Usd Million)

Table 250 Mexico: Standalone Software Market, By Type, 2022–2029 (Usd Million)

Table 251 Mexico: Digital Pathology Market For Software,

By Deployment Model, 2022–2029 (Usd Million)

Table 252 Mexico: Digital Pathology Market, By Type, 2022–2029 (Usd Million)

Table 253 Mexico: Digital Pathology Market, By Application,

2022–2029 (Usd Million)

Table 254 Mexico: Digital Pathology Market, By End User, 2022–2029 (Usd Million)

Table 255 Rest Of Latin America: Digital Pathology Market,

By Product, 2022–2029 (Usd Million)

Table 256 Rest Of Latin America: Digital Pathology Market For Scanners,

By Type, 2022–2029 (Usd Million)

Table 257 Rest Of Latin America: Digital Pathology Market For Software,

By Type, 2022–2029 (Usd Million)

Table 258 Rest Of Latin America: Standalone Software Market,

By Type, 2022–2029 (Usd Million)

Table 259 Rest Of Latin America: Digital Pathology Market For Software,

By Deployment Model, 2022–2029 (Usd Million)

Table 260 Rest Of Latin America: Digital Pathology Market,

By Type, 2022–2029 (Usd Million)

Table 261 Rest Of Latin America: Digital Pathology Market,

By Application, 2022–2029 (Usd Million)

Table 262 Rest Of Latin America: Digital Pathology Market,

By End User, 2022–2029 (Usd Million)

Table 263 Middle East & Africa: Digital Pathology Market,

By Country, 2022–2029 (Usd Million)

Table 264 Middle East & Africa: Digital Pathology Market,

By Product, 2022–2029 (Usd Million)

Table 265 Middle East & Africa: Digital Pathology Market For Scanners,

By Type, 2022–2029 (Usd Million)

Table 266 Middle East & Africa: Digital Pathology Market For Software,

By Type, 2022–2029 (Usd Million)

Table 267 Middle East & Africa: Standalone Software Market,

By Type, 2022–2029 (Usd Million)

Table 268 Middle East & Africa: Digital Pathology Market For Software,

By Deployment Model, 2022–2029 (Usd Million)

Table 269 Middle East & Africa: Digital Pathology Market,

By Type, 2022–2029 (Usd Million)

Table 270 Middle East & Africa: Digital Pathology Market,

By Application, 2022–2029 (Usd Million)

Table 271 Middle East & Africa: Digital Pathology Market,

By End User, 2022–2029 (Usd Million)

Table 272 Gcc Countries: Digital Pathology Market,

By Product, 2022–2029 (Usd Million)

Table 273 Gcc Countries: Digital Pathology Market For Scanners,

By Type, 2022–2029 (Usd Million)

Table 274 Gcc Countries: Digital Pathology Market For Software,

By Type, 2022–2029 (Usd Million)

Table 275 Gcc Countries: Standalone Software Market,

By Type, 2022–2029 (Usd Million)

Table 276 Gcc Countries: Digital Pathology Market For Software,

By Deployment Mode, 2022–2029 (Usd Million)

Table 277 Gcc Countries: Digital Pathology Market,

By Type, 2022–2029 (Usd Million)

Table 278 Gcc Countries: Digital Pathology Market,

By Application, 2022–2029 (Usd Million)

Table 279 Gcc Countries: Digital Pathology Market,

By End User, 2022–2029 (Usd Million)

Table 280 Rest Of Middle East & Africa: Digital Pathology Market,

By Product, 2022–2029 (Usd Million)

Table 281 Rest Of Middle East & Africa: Digital Pathology Market For Scanners, By Type, 2022–2029 (Usd Million)

Table 282 Rest Of Middle East & Africa: Digital Pathology Market

For Software, By Type, 2022–2029 (Usd Million)

Table 283 Rest Of Middle East & Africa: Standalone Software Market,

By Type, 2022–2029 (Usd Million)

Table 284 Rest Of Middle East & Africa: Digital Pathology Market

For Software, By Deployment Model, 2022–2029 (Usd Million)

Table 285 Rest Of Middle East & Africa: Digital Pathology Market,

By Type, 2022–2029 (Usd Million)

Table 286 Rest Of Middle East & Africa: Digital Pathology Market,

By Application, 2022–2029 (Usd Million)

Table 287 Rest Of Middle East & Africa: Digital Pathology Market,

By End User, 2022–2029 (Usd Million)

Table 288 Overview Of Strategies Deployed By Key Manufacturing Companies

Table 289 Digital Pathology Market: Degree Of Competition

Table 290 Digital Pathology Market: Product Footprint

Table 291 Digital Pathology Market: Application Footprint

Table 292 Digital Pathology Market: End-user Footprint

Table 293 Digital Pathology Market: Region Footprint

Table 294 Digital Pathology Market: Detailed List Of Key Start-ups/Smes

Table 295 Digital Pathology Market: Competitive Benchmarking Of Key Emerging Players/Startups

Table 296 Digital Pathology Market: Product Launches, Enhancements,

And Approvals, January 2021–march 2024

Table 297 Digital Pathology Market: Digital Pathology Market:

Deals, January 2021–march 2024

Table 298 Digital Pathology Market: Other Developments,

January 2021–march 2024

Table 299 Danaher Corporation: Company Overview

Table 300 Danaher Corporation: Products Offered

Table 301 Danaher Corporation: Product Enhancements, January 2021−june 2024

Table 302 Koninklijke Philips N.V.: Company Overview

Table 303 Koninklijke Philips N.V.: Products Offered

Table 304 Koninklijke Philips N.V: Product Launches, January 2021–june 2024

Table 305 Koninklijke Philips N.V.: Deals, January 2021−june 2024

Table 306 Hamamatsu Photonics K.K.: Company Overview

Table 307 Hamamatsu Photonics K.K.: Products Offered

Table 308 Hamamatsu Photonics K.K.: Product Approvals, January 2021–june 2024

Table 309 Hamamatsu Photonics K.K.: Deals, January 2021–june 2024

Table 310 F. Hoffmann-la Roche Ltd.: Company Overview

Table 311 F. Hoffmann-la Roche Ltd.: Products Offered

Table 312 Hoffmann-la Roche Ltd.: Product Launches & Approvals,

January 2021–june 2024

Table 313 Hoffmann-la Roche Ltd.: Deals, January 2021–june 2024

Table 314 Sectra Ab: Company Overview

Table 315 Sectra Ab: Products Offered

Table 316 Sectra Ab: Deals, January 2021–june 2024

Table 317 Sectra Ab: Other Developments, January 2021–june 2024

Table 318 Akoya Biosciences, Inc.: Company Overview

Table 319 Akoya Biosciences, Inc.: Products Offered

Table 320 Akoya Biosciences, Inc.: Product Launches & Approvals,

January 2021–june 2024

Table 321 Akoya Biosciences, Inc.: Deals, January 2021–june 2024

Table 322 Fujifilm Holdings Corporation: Company Overview

Table 323 Fujifilm Holdings Corporation: Products Offered

Table 324 Fujifilm Holdings Corporation: Deals, January 2021–june 2024

Table 325 Hologic, Inc: Company Overview

Table 326 Hologic, Inc: Products Offered

Table 327 Hologic, Inc: Product Approvals, January 2021–june 2024

Table 328 3dhistech Ltd.: Company Overview

Table 329 3dhistech Ltd.: Products Offered

Table 330 3dhistech Ltd.: Product Launches & Enhancements,

January 2021–june 2024

Table 331 3dhistech Ltd.: Other Developments, January 2021–june 2024

Table 332 Apollo Enterprise Imaging Corp.: Company Overview

Table 333 Apollo Enterprise Imaging Corp.: Products Offered

Table 334 Apollo Enterprise Imaging Corp.: Product Enhancements,

January 2021–june 2024

Table 335 Apollo Enterprise Imaging Corp.: Deals, January 2021–june 2024

Table 336 Xifin, Inc.: Company Overview

Table 337 Xifin, Inc.: Products Offered

Table 338 Xifin, Inc.: Product Launches, January 2021–june 2024

Table 339 Xifin, Inc.: Deals, January 2021–june 2024

Table 340 Huron Digital Pathology: Company Overview

Table 341 Huron Digital Pathology: Products Offered

Table 342 Huron Digital Pathology: Product Approvals, January 2021–june 2024

Table 343 Huron Digital Pathology: Deals, January 2021–june 2024

Table 344 Huron Digital Pathology: Other Developments,

January 2021–june 2024

Table 345 Corista: Company Overview

Table 346 Corista: Products Offered

Table 347 Corista: Deals, January 2021–june 2024

Table 348 Corista: Other Developments, January 2021–june 2024

Table 349 Indica Labs: Company Overview

Table 350 Indica Labs: Products Offered

Table 351 Indica Labs: Product Launches & Approvals, January 2021–june 2024

Table 352 Indica Labs: Deals, January 2021–june 2024

Table 353 Objective Pathology Services: Company Overview

Table 354 Objective Pathology Services: Products Offered

Table 355 Optrascan, Inc.: Company Overview

Table 356 Optrascan, Inc.: Products Offered

Table 357 Optrascan, Inc.: Product Launches & Approvals,

January 2021–june 2024

Table 358 Optrascan, Inc.: Deals, January 2021–june 2024

Table 359 Glencoe Software, Inc.: Company Overview

Table 360 Glencoe Software, Inc.: Products Offered

Table 361 Glencoe Software, Inc.: Product Enhancements,

January 2021–june 2024

Table 362 Aiforia Technologies Oy: Company Overview

Table 363 Aiforia Technologies Oy: Products Offered

Table 364 Aiforia Technologies Oy: Deals, January 2021–june 2024

Table 365 Paige Ai, Inc.: Company Overview

Table 366 Paige Ai, Inc.: Products Offered

Table 367 Paige Ai, Inc.: Product Launches & Enhancements,

January 2021–june 2024

Table 368 Paige Ai, Inc.: Deals, January 2021–june 2024

Table 369 Proscia, Inc.: Company Overview

Table 370 Proscia, Inc.: Products Offered

Table 371 Proscia, In c.: Product Enhancements & Approvals,

January 2021–june 2024

Table 372 Proscia, Inc.: Deals, January 2021–june 2024

List of Figures

Figure 1 Digital Pathology Market

Figure 2 Research Design

Figure 3 Primary Sources

Figure 4 Breakdown Of Primary Interviews: By Demand Side, Supply Side, Designation, And Region

Figure 5 Research Methodology: Hypothesis Building

Figure 6 Market Size Estimation: Revenue Share Analysis

Figure 7 Digital Pathology Market: Revenue Share Analysis Illustration Of Danaher Corporation

Figure 8 Bottom-up Approach

Figure 9 Cagr Projections: Supply-side Analysis

Figure 10 Cagr Projections From Analysis Of Drivers, Restraints, Opportunities, And Challenges In Digital Pathology Market (2024–2029)

Figure 11 Data Triangulation Methodology

Figure 12 Digital Pathology Market, By Product, 2024 Vs. 2029 (Usd Million)

Figure 13 Digital Pathology Market, By Type, 2024 Vs. 2029 (Usd Million)

Figure 14 Digital Pathology Market, By Application, 2024 Vs. 2029 (Usd Million)

Figure 15 Digital Pathology Market, By End User, 2024 Vs. 2029 (Usd Million)

Figure 16 Geographic Snapshot Of Digital Pathology Market

Figure 17 Rising Incidence Of Cancer And Growing Adoption Of Pathology Solutions For Enhanced Lab Efficiency To Drive Market

Figure 18 Pharmaceutical & Biotechnology Companies Accounted

For Largest Market Share In 2023

Figure 19 Uk To Grow At Highest Cagr During Forecast Period

Figure 20 Asia Pacific Segment To Dominate Market During Forecast Period

Figure 21 Digital Pathology Market: Drivers, Restraints, Opportunities,

And Challenges

Figure 22 Global Cancer Incidence, 2008−2030

Figure 23 Fda-approved Personalized Medicines, 2015−2021

Figure 24 Digital Pathology Market: Value Chain Analysis

Figure 25 Digital Pathology Market: Ecosystem Analysis

Figure 26 Digital Pathology Market: Porter’s Five Forces Analysis

Figure 27 Europe: Ivdr Timeline

Figure 28 Jurisdiction Analysis: Top Applicant Countries For Digital Pathology Patents, 2013–2023

Figure 29 Major Patents For Digital Pathology (2013–2023)

Figure 30 Key Buying Criteria For Digital Pathology Products

Figure 32 Market Potential Of Generative Ai In Enhancing Digital Pathology Across Industries

 

Figure 33 Impact Of Gen Ai On Interconnected And Adjacent Ecosystems

Figure 34 North America: Digital Pathology Market Snapshot

Figure 35 Europe: Digital Pathology Market Snapshot

Figure 36 Revenue Analysis Of Key Players In Digital Pathology Market

Figure 37 Digital Pathology Market: Market Share Analysis (2023)

Figure 38 Digital Pathology Market: Company Evaluation Matrix

(Key Players), 2023

Figure 39 Digital Pathology Market: Company Footprint

Figure 40 Digital Pathology Market: Company Evaluation Matrix

(Startups/Smes), 2023

Figure 41 Ev/Ebitda Of Key Vendors

Figure 42 Year-to-date (Ytd) Price Total Return And 5-year Stock Beta Of Digital Pathology Vendors

Figure 43 Danaher Corporation: Company Snapshot (2023)

Figure 44 Koninklijke Philips N.V.: Company Snapshot (2023)

Figure 45 Hamamatsu Photonics K.K.: Company Snapshot (2023)

Figure 46 F. Hoffmann-la Roche Ltd.: Company Snapshot (2023)

Figure 47 Sectra Ab.: Company Snapshot (2023)

Figure 48 Akoya Biosciences, Inc.: Company Snapshot (2023)

Figure 49 Fujifilm Holdings Corporation: Company Snapshot (2022)

Figure 50 Hologic, Inc: Company Snapshot (2023)